Business Context and Reporting Period
This Form 8-K is a current report filed by Inpixon (trading symbol: INPX) on February 5, 2020. The filing addresses two primary corporate events: a regulatory update regarding the company's listing status on The Nasdaq Capital Market and the unregistered issuance of equity securities in exchange for outstanding debt.
Key Financial Metrics and Capital Structure
The filing does not provide standard financial performance metrics such as revenue, profit, cash flow, or operating margins. However, it discloses specific capital structure updates:
- Outstanding Shares: As of February 7, 2020, the company had approximately 4,874,062 shares of common stock issued and outstanding.
- Debt-to-Equity Exchange: The company issued 228,182 shares of common stock to a noteholder.
- Transaction Value: The exchange reduced the outstanding balance of promissory notes by an aggregate principal amount of $808,679.02.
- Issuance Price: The shares were issued at an average price of approximately $3.544 per share, calculated based on the Nasdaq Minimum Price requirement.
Material Changes and Corporate Events
Nasdaq Listing Status
On February 5, 2020, the Nasdaq Hearings Panel granted Inpixon's request to continue the listing of its common stock. The Panel determined the company had demonstrated compliance with the minimum bid price requirement (Nasdaq Listing Rule 5550(a)(2)) for twelve consecutive trading days as of the January 23, 2020 hearing.
Panel Monitor Imposition
As a condition of the continued listing, the Panel imposed a Panel Monitor effective immediately and lasting until February 5, 2021. During this period, the company must immediately notify the Panel if its bid price falls below the minimum requirement for any reason or if it fails to meet other listing requirements. Failure to maintain compliance for 30 consecutive trading days could trigger a Staff Delisting Determination.
Unregistered Securities Issuance
The issuance of 228,182 shares was conducted under Section 3(a)(9) of the Securities Act of 1933. This exemption applies because the shares were issued in exchange for an existing security (partitioned notes) with no additional consideration or commissions paid.
Guidance, Risks, and Contingencies
The filing contains no forward-looking guidance regarding future revenue, earnings, or operational plans. The primary risks and contingencies identified are:
- Delisting Risk: The company remains under a monitoring period until February 5, 2021. If the stock price falls below the minimum bid price for 30 consecutive trading days, the company faces potential delisting.
- Regulatory Review: The Nasdaq Listing and Hearing Review Council retains the right to review the Panel's decision within 45 days, potentially affirming, modifying, or reversing the decision to continue the listing.
- Forward-Looking Statements: The company explicitly states that actual results may differ materially from expectations regarding the maintenance of listing compliance.
Investor Verification Checklist
- Verify the current trading price of INPX to ensure it remains above the Nasdaq minimum bid price requirement ($1.00) to avoid triggering the 30-day delisting clock.
- Confirm the total outstanding share count of 4,874,062 in subsequent filings to monitor for further dilution.
- Monitor for any communication from the Nasdaq Listing Council within 45 days of the February 5, 2020 decision regarding a potential review.
- Review the company's most recent 10-K or 10-Q for comprehensive financial data, as this 8-K does not contain revenue or profit figures.